CO154 Ramucirumab+Docetaxel Post Immune Checkpoint Inhibitors (ICIS) and Platinum-Based Chemotherapy (CHEMO) in Advanced or Metastatic Non-Small Cell Lung Cancer (ANSCLC): Learnings from the Treat-Lung Observational Study

Autor: Pennell, NA, Clarke, JM, Liu, S, Gutierrez, M, Batus, M, Bauman, J, Fidler, MJ, Marmarelis, ME, Feliciano, J, Barzi, A, Lopes, G, Molife, C, Verma, S, Stefaniak, VJ, Winfree, KB, Belli, A, Cui, Z, Kim, S, Manion, C, Afolabi, M, Caria, N, Bonomi, P
Zdroj: In Value in Health July 2022 25(7) Supplement:S333-S333
Databáze: ScienceDirect
Externí odkaz: